Agilent Technologies (NYSE:A) Given New $125.00 Price Target

Agilent Technologies (NYSE:A – Free Report) had its price objective reduced by Barclays from $135.00 to $125.00 in a report released on Friday, Benzinga reports. They currently have an underweight rating on the medical research company’s stock. Other equities research analysts have also recently issued reports about the stock. Stifel Nicolaus cut their price target […]

Related Keywords

United States , America , Stifel Nicolaus , Agilent Crosslab , Philip Binns , Agilent Technologies Inc , Agilent Technologies Company Profile , Visionpoint Advisory Group , Life Sciences , Agilent Technologies , Jpmorgan Chase Co , Mv Capital Management Inc , Barclays , Rise Advisors , Investment Advisors Inc , Free Report , Moderate Buy , Get Free Report , Director Heidi Fields , Financial Advisory , Point Advisory Group , Applied Markets , Agilent Technologies Daily ,